ANTIBACTERIAL TREATMENT OF INFECTIOUS EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN OUTPATIENT SETTINGS
- Authors: Botova Z.O.1, Stepanishcheva L.A.1, Botova Z.O1, Stepfnishceva LA1
-
Affiliations:
- Issue: No 18 (2011)
- Pages: 59-62
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279097
- ID: 279097
Cite item
Full Text
Abstract
The effectiveness of azithromycin (Hemomycin, Hemofarm A.D) in relieving of infection-induced exacerbations of chronic obstructive pulmonary disease (COPD) in 35 outpatients without severe respiratory failure is evaluated. Application of Hemomycin led to a significant decrease in frequency and intensity of fit of coughing, severity of dyspnea, reduction of leukocytosis, normalization of erythrocyte sedimentation rate, reduction in the incidence of infectious exacerbations at follow-up. Hemomycin can be considered as one of the drugs that are preferred for the relief of infection-induced exacerbations of COPD in the outpatient settings.
Keywords
About the authors
Zhanna Olegovna Botova
Larisa Aleksandrovna Stepanishcheva
Zh O Botova
L A Stepfnishceva
References
- Roche N, Huchon G. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J 2001;18(6):903-08.
- Anto JM, Vermeire.P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001;17(5):982-94.
- Mapel D, Chen JC, George D, Halbert R. The cost of chronic obstructive pulmonary disease and its effects on managed care. Manag Care Interface 2004;17(4):61-66.
- Синопальников А.И., Козлов Р.С. Внебольничные инфекции дыхательных путей. Руководство для врачей. М., 2007.
- Snider GL. Nosology for our day: its application to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167(8):1045-46.
- Авдеев С.Н. Хроническая обструктивная болезнь легких. М., 2008
- Nationa Collaborating Center for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59 (1) 1-232.
- Yap FH, Ho PL, Lam KF, et al. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 2004;73(4):617-23.
- Страчунский Л.С., Белоусов Ю.Б., Козлов Р.С. Практическое руководство по антиинфекционной химиотерапии. 2007. С. 258-63.
- Andre-Alves MR, Jardim JR, Frare e Silva R, et al. Comparison between azithromycin and amoxicillin in the treatment of infectious exacerbation of chronic obstructive pulmonary disease. J Bras Pneumol 2007;33(1):43-50.
- Parnham MJ,.Culić O, Eraković V, et al. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. Eur J Pharmacol 2005;517(1-2):132-43.
- Hodge S, Hodge G, Jersmann H, et al. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178(2):139-48.
Supplementary files
